对于Chalazion的强脉冲光:一个单臂前性队列研究,共61名患者
Qiu Yan1, Zeyi Li1, Zhuoyi Hu1
1Department of Ophthalmology, Joint Shantou International Eye Center of Shantou University, Chinese University of Hong Kong, Shantou, China.
Photobiomodulation, photomedicine, and laser surgery
|February 24, 2026
概括
强烈脉冲光 (IPL) 治疗显示了77.0%的沙拉齐安的解决率,这是一个常见的眼状况. 较短的症状持续时间和更多的IPL疗程与成功的治疗结果有关.
科学领域:
- 眼科医生 眼科 眼科
- 皮肤病学 皮肤病学
背景情况:
- 查拉齐安是一种普遍的眼疾病,治疗选择有限.
- 强脉冲光 (IPL) 对梅博米腺功能障碍有希望,但其用于查拉齐安需要更多的研究.
研究的目的:
- 为了评估强烈脉冲光 (IPL) 治疗查拉齐安的临床结果.
- 为了确定影响IPL治疗后病变解决的因素.
主要方法:
- 一个单一中心的前性队列研究,涉及61名患有沙拉的患者.
- 患者每周接受IPL治疗,结果在最后一次治疗后进行评估.
- 统计分析包括描述性统计,奇平方测试和弹性净惩罚后勤回归.
主要成果:
- 在IPL治疗后,观察到77.0%的整体损伤解决率.
- 较短的症状持续时间 (≤30天) 和较多的IPL疗程 (≥2) 与病变解决显著相关.
- 两个会议[aOR 3.685]和≥3个会议[aOR 40.844]相比于一个会议,增加了解决方案的几率. 症状持续时间 ≤7天 [aOR 21.101] 和 8-30天 [aOR 3.430] 与>30天相比,成功几率增加.
- 预测模型显示可接受的性能 (AUC = 0.887),没有报告严重不良事件.
结论:
- 在这项前性队列研究中,强烈脉冲光 (IPL) 治疗显示出77.0%的病变解脱率.
- 虽然有希望,但这些发现来自没有对照组的观察性研究.
- 进一步的受控试验是必要的,以确定因果关系,因为自发 chalazion 解决的潜力.
相关概念视频
Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K


